SS
CMPX icon

SBI Securities’s Compass Therapeutics CMPX Stock Holding History

SBI Securities’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394 Sell
180
-4
-2% -$12 ﹤0.01% 3120
2026
Q1 		$973 Sell
184
-53
-22% -$306 ﹤0.01% 2663
2025
Q4 		$1.27K Sell
237
-93
-28% -$429 ﹤0.01% 2552
2025
Q3 		$1.16K Sell
330
-24
-7% -$76 ﹤0.01% 2637
2025
Q2 		$920 Hold
354
– – ﹤0.01% 2717
2025
Q1 		$673 Sell
354
-54
-13% -$144 ﹤0.01% 2749
2024
Q4 		$592 Buy
+408
New +$678 ﹤0.01% 2831

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SBI Securities's CMPX Position: Q2 2026 in Review

SBI Securities reduced its Compass Therapeutics (CMPX) stake by 2.2% in Q2 2026, selling an estimated $12 and leaving 180 shares worth $394. The position accounts for ﹤0.01% of the portfolio, ranked #3120.

SBI Securities first reported a position in CMPX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.27K in Q4 2025. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • SBI Securities held 180 shares of Compass Therapeutics worth $394 as of Q2 2026.
  • SBI Securities sold 4 Compass Therapeutics shares in Q2 2026, an estimated $12.
  • Compass Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3120 holding.
  • SBI Securities first reported a position in Compass Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Compass Therapeutics position peaked at $1.27K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.